Charles E. Weeks

1.7k citations
29 papers · 1.4k indexed · h-index 19

Charles E. Weeks

29 papers receiving 1.3k citations

Peers

Charles E. Weeks
Comparison fields: 5 of 104
  • Biochemistry 187
  • Cancer Research 290
  • Immunology 259
  • Dermatology 101
  • Molecular Biology 642
Replace Karen J. Auborn with:
Karen J. Auborn United States
Amy Liem United States
Bill E. Cham Australia
Sudha Iyer United States
Kasthuri Natarajan India
Alan Warbritton United States
Shijun He China
Marco Giaisi Germany
Steven R. Lear United States
David L. Berry United States
Charles E. Weeks relative to Karen J. Auborn United States Karen J. Auborn's profile →
Citations per field
00.5×5.2×
Karen J. Auborn · 1×
Citations per year

Countries citing papers authored by Charles E. Weeks

Since Specialization
Citations

This map shows the geographic impact of Charles E. Weeks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Weeks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Weeks more than expected).

Fields of papers citing papers by Charles E. Weeks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Weeks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Weeks. The network helps show where Charles E. Weeks may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Charles E. Weeks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles E. Weeks Line = papers co-authored together Charles E. Weeks links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200048
2 200012
3 19996
4 199912
5 199822
6 199492
7 1994151
8
Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine.
1992145
9 198917
10 198824
11 198411
12 1982135
13 1982122
14
Specificity and mechanism(s) of promoter inhibitors in multistage promotion.
198232
15
Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538.
198034
16 197921
17 197953
18
Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
197864
19 19775
20 197527

About Charles E. Weeks

Charles E. Weeks is a scholar working on Biochemistry, Cancer Research, Clinical Biochemistry, Toxicology and Molecular Biology, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Polyamine Metabolism and Applications (8 papers), Amino Acid Enzymes and Metabolism (6 papers), Carcinogens and Genotoxicity Assessment (6 papers), Estrogen and related hormone effects (6 papers), Epigenetics and DNA Methylation (2 papers), Metabolism and Genetic Disorders (2 papers), Phytoestrogen effects and research (2 papers) and Hormonal and reproductive studies (2 papers). The work is most often cited by research in Biochemistry (187 citations), Cancer Research (290 citations), Immunology (259 citations), Dermatology (101 citations) and Molecular Biology (642 citations). Charles E. Weeks has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Thomas J. Slaga, Andres J. Klein–Szanto, Susan M. Fischer, Frederick Nelson, Michael J. Reiter, Mark A. Tomai, Richard L. Miller, Mahmoud M. Abdel‐Monem, John J. Reiners and Ernest C. Borden. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemical and Biophysical Research Communications, Carcinogenesis, The Journal of Clinical Pharmacology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026